Bharat Biotech completes clinical development for nasal vaccine

Hyderabad (Telangana) [India], August 15 (ANI): Bharat Biotech International on Monday said that BBV154 (intranasal...

BB's COVID-19 nasal vaccine phase III trials completed

Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local...

Phase 2,3 trial data of India's first mRNA COVID vaccine...

New Delhi [India], March 18 (ANI): Pune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III...

AstraZeneca booster dose works against Omicron, says Oxford...

London [UK], December 23 (ANI): The University of Oxford, in collaboration with AstraZeneca, has announced interim...

Glenmark to conduct phase III trials of nasal spray it claims...

New Delhi [India], July 8 (ANI): Glenmark Pharmaceuticals will be conducting a Phase III trial on a nasal spray,...

Bharat Biotech's Covaxin shows 77.8 pc efficacy in Phase III...

New Delhi [India], June 22 (ANI): Bharat Biotech's Covaxin has shown 77.8 per cent efficacy after the Subject Expert...

'Covaxin shows overall 78 pc interim efficacy, 100 pc...

Hyderabad (Telangana) [India], April 21 (ANI): Covaxin, India's indigenous vaccine against COVID-19 demonstrated...

Unseemly haste risks jeopardising India's good reputation:...

New Delhi [India], January 4 (ANI): A day after Union Civil Aviation Minister Hardeep Singh Puri called Shashi...

Bharat Biotech starts phase III trials for COVAXIN

Hyderabad [India], November 17, (ANI): Bharat Biotech announced the commencement of Phase III trials of COVAXIN on...

Keeping Pfizer's COVID-19 vaccine at low temperatures will be...

New Delhi [India], November 11 (ANI): Dr Randeep Guleria, Director, All India Institute of Medical Sciences Delhi...

Dr Reddy's Laboratories seeks DCGI permission to conduct...

New Delhi [India], October 2 (ANI): Indian pharma giant Dr Reddy's Laboratories (DRL) has submitted an...